首页> 外文期刊>Blood cells, molecules and diseases >Development of a fluorescence immunochromatographic assay for the detection of zeta globin in the blood of (-- SEA) α-thalassemia carriers
【24h】

Development of a fluorescence immunochromatographic assay for the detection of zeta globin in the blood of (-- SEA) α-thalassemia carriers

机译:荧光免疫色谱法开发用于检测(-SEA)α地中海贫血携带者血液中的Zeta珠蛋白的方法

获取原文
获取原文并翻译 | 示例
       

摘要

Southeast Asian deletion (-- SEA) α-thalassemia is an inherited monogenic disorder of human hemoglobin, and embryonic globin ζ (hemoglobin ζ, zeta globin chain or Hb zeta chain) has been shown to be a marker that can be used for the identification of carriers of the (-- SEA) α-thalassemia deletion. In this work, a fluorescence immunochromatographic assay (FL-ICA) was established to detect the zeta globin chain in the hemolysates of carriers of the (-- SEA) α-thalassemia deletion. This assay can be completed within 10min using a simple UV detector and does not suffer from interference from the red background color of the hemolysate. A total of 314 blood samples were tested by FL-ICA and ELISA. The results of these assays were confirmed by PCR, the standard technique for genetic disease testing. The sensitivity and specificity of this novel FL-ICA were 100% and 98.0%, respectively; the corresponding values for the ELISA performed simultaneously were 100% and 99.2%, respectively. In conclusion, a new FL-ICA-a simple, fast, convenient, low-cost method-was developed that may be useful in both high-throughput screening and individual detection of the (-- SEA) α-thalassemia deletion in carriers. Additionally, this qualitative FL-ICA may enlighten the development of a new systems for analysis of other target molecules using whole-blood samples.
机译:东南亚缺失(-SEA)α-地中海贫血是人类血红蛋白的遗传性单基因疾病,并且已证明胚胎球蛋白ζ(血红蛋白ζ,zeta球蛋白链或Hb zeta链)是可用于鉴定的标记物(-SEA)α-地中海贫血缺失携带者的数量。在这项工作中,建立了荧光免疫色谱分析(FL-ICA)以检测(-SEA)α地中海贫血缺失的载体的溶血产物中的ζ珠蛋白链。使用简单的紫外线检测器可以在10分钟内完成该测定,并且不会受到溶血产物红色背景色的干扰。通过FL-ICA和ELISA测试了总共314个血液样本。这些测定的结果已通过PCR(一种遗传疾病检测的标准技术)得到了证实。该新型FL-ICA的敏感性和特异性分别为100%和98.0%;同时进行的ELISA的相应值分别为100%和99.2%。总之,开发了一种新的FL-ICA-一种简单,快速,方便,低成本的方法,该方法可用于高通量筛查和个体检测(-SEA)α地中海贫血携带者中的缺失。此外,这种定性的FL-ICA可能会启发开发使用全血样品分析其他目标分子的新系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号